These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 28877509)

  • 1. Botulinum toxin for chronic migraine: Clinical trials and technical aspects.
    Tassorelli C; Sances G; Avenali M; De Icco R; Martinelli D; Bitetto V; Nappi G; Sandrini G
    Toxicon; 2018 Jun; 147():111-115. PubMed ID: 28877509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An academic debate: OnabotulinumtoxinA for chronic migraine: PREEMPT-derived vs "customized" dosing/injection paradigm.
    Green MW; Rothrock JF
    Toxicon; 2018 Jun; 147():116-119. PubMed ID: 29596847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimizing the long-term management of chronic migraine with onabotulinumtoxinA in real life.
    Tassorelli C; Tedeschi G; Sarchielli P; Pini LA; Grazzi L; Geppetti P; De Tommaso M; Aguggia M; Cortelli P; Martelletti P
    Expert Rev Neurother; 2018 Feb; 18(2):167-176. PubMed ID: 29280408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of onabotulinumtoxinA for chronic migraine.
    Whitcup SM; Turkel CC; DeGryse RE; Brin MF
    Ann N Y Acad Sci; 2014 Nov; 1329():67-80. PubMed ID: 25399521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term treatment of chronic migraine with OnabotulinumtoxinA: efficacy, quality of life and tolerability in a real-life setting.
    Kollewe K; Escher CM; Wulff DU; Fathi D; Paracka L; Mohammadi B; Karst M; Dressler D
    J Neural Transm (Vienna); 2016 May; 123(5):533-40. PubMed ID: 27032774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Real-life use of onabotulinumtoxinA for symptom relief in patients with chronic migraine: REPOSE study methodology and baseline data.
    Davies B; Gaul C; Martelletti P; García-Moncó JC; Brown S
    J Headache Pain; 2017 Sep; 18(1):93. PubMed ID: 28879545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utilization and safety of onabotulinumtoxinA for the prophylactic treatment of chronic migraine from an observational study in Europe.
    Matharu M; Pascual J; Nilsson Remahl I; Straube A; Lum A; Davar G; Odom D; Bennett L; Proctor C; Gutierrez L; Andrews E; Johannes C
    Cephalalgia; 2017 Dec; 37(14):1384-1397. PubMed ID: 28758415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic migraine treatment: from OnabotulinumtoxinA onwards.
    Negro A; Curto M; Lionetto L; Giamberardino MA; Martelletti P
    Expert Rev Neurother; 2016 Oct; 16(10):1217-27. PubMed ID: 27310178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An open-label prospective study of the real-life use of onabotulinumtoxinA for the treatment of chronic migraine: the REPOSE study.
    Ahmed F; Gaul C; García-Moncó JC; Sommer K; Martelletti P;
    J Headache Pain; 2019 Mar; 20(1):26. PubMed ID: 30845917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Technique of injection of onabotulinumtoxin A for chronic migraine: the PREEMPT injection paradigm.
    Liberini P; Pari E; Gazzina S; Caratozzolo S; Rao R; Padovani A
    Neurol Sci; 2014 May; 35 Suppl 1():41-3. PubMed ID: 24867834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quarterly repeat cycles of onabotulinumtoxinA in chronic migraine patients: the benefits of the prolonged treatment on the continuous responders and quality-of-life conversion rate in a real-life setting.
    Santoro A; Fontana A; Miscio AM; Zarrelli MM; Copetti M; Leone MA
    Neurol Sci; 2017 Oct; 38(10):1779-1789. PubMed ID: 28726049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Onabotulinum toxin A (Botox) for chronic migraine treatment: an Italian experience.
    Grazzi L; Usai S
    Neurol Sci; 2015 May; 36 Suppl 1():33-5. PubMed ID: 26017508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term study of the efficacy and safety of OnabotulinumtoxinA for the prevention of chronic migraine: COMPEL study.
    Blumenfeld AM; Stark RJ; Freeman MC; Orejudos A; Manack Adams A
    J Headache Pain; 2018 Feb; 19(1):13. PubMed ID: 29404713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rationale for use of onabotulinum toxin A (BOTOX) in chronic migraine.
    Barbanti P; Egeo G; Fofi L; Aurilia C; Piroso S
    Neurol Sci; 2015 May; 36 Suppl 1():29-32. PubMed ID: 26017507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Not Available].
    Sundal C; Tedroff J
    Lakartidningen; 2018 May; 115():. PubMed ID: 29762814
    [No Abstract]   [Full Text] [Related]  

  • 16. Increased efficacy of regularly repeated cycles with OnabotulinumtoxinA in MOH patients beyond the first year of treatment.
    Guerzoni S; Pellesi L; Baraldi C; Pini LA
    J Headache Pain; 2015; 17():48. PubMed ID: 27146068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insights into the Functional Anatomy Behind the PREEMPT Injection Paradigm: Guidance on Achieving Optimal Outcomes.
    Blumenfeld AM; Silberstein SD; Dodick DW; Aurora SK; Brin MF; Binder WJ
    Headache; 2017 May; 57(5):766-777. PubMed ID: 28387038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A two years open-label prospective study of OnabotulinumtoxinA 195 U in medication overuse headache: a real-world experience.
    Negro A; Curto M; Lionetto L; Martelletti P
    J Headache Pain; 2015; 17():1. PubMed ID: 26792662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Real-world economic impact of onabotulinumtoxinA in patients with chronic migraine.
    Rothrock JF; Bloudek LM; Houle TT; Andress-Rothrock D; Varon SF
    Headache; 2014; 54(10):1565-73. PubMed ID: 25298117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Narrative Review of Evidence-Based Preventive Options for Chronic Migraine.
    Starling AJ; Vargas BB
    Curr Pain Headache Rep; 2015 Oct; 19(10):49. PubMed ID: 26286071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.